Exactly a month after it announced the removal of black box warning labels on estrogen therapy products used in menopause, the Food and Drugs ...

Congress is poised to pass the Biosecure Act after two years of incremental changes that watered down the bill’s curbs on Chinese biotechs ...

High costs, quiet-period rules, investor skepticism, and lingering safety concerns are pushing major insurers to once again ...

Study points to source of "very, very rare" cases of myocarditis and potential solutions. Myocarditis risk remains far higher ...

The Food and Drug Administration this week granted approval to a new gene therapy for a rare immune disorder, the maker of which is notably not a drug ...

Deputy health secretary Jim O’Neill demurred when asked about a proposal to prevent states from enforcing local AI laws.

Health system lawyers are silent on why hospitals don't keep AI scribe transcripts for quality and accuracy research.

Morning! Today, we preview a contentious generic drug dispute that may end up at the Supreme Court, discuss how the FDA’s new ...

In a closely watched case, the U.S. solicitor general urged the Supreme Court to review a controversy over so-called skinny ...

More than 100,000 people are enrolled in M.D. programs for the 2025-2026 academic year, according to data released yesterday by the Association of American Medical Colleges. It’s the first time total ...

Care for patients with dementia has changed radically since Jason Karlawish started working in the field in the late ’90s, he says on STAT’s “First Opinion Podcast.” ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — A sperm donor who unknowingly carried a gene variant that can ...